Moody's Investors Service

Anti-obesity medication in a tiny shopping cart

GLP-1 sales surge to power industry earnings growth: Moody's

Thanks to GLP-1 meds and oncology blockbusters, Moody's has moved its 12- to 18-month industry earnings outlook to "positive."

Zoey Becker Mar 15, 2024 9:50am

Inflation Reduction Act

Amgen, J&J to see largest impact from IRA negotiations: Moody's

Sep 7, 2023 9:05am

doctor measures the waist of an overweight male patient

Obesity drugs carry blockbuster potential, risks for Big Pharma

May 23, 2023 10:10am

Mergers Acquisitions

Patent cliffs face BMS, Merck, Pfizer but all can pull off M&A

Jun 21, 2022 4:14pm